West Pharmaceutical Services (WST) stock price, revenue, and financials

West Pharmaceutical Services market cap is $21.3 b, and annual revenue was $1.84 b in FY 2019

$21.3 B

WST Mkt cap, 23-Sept-2020

$527.2 M

West Pharmaceutical Services Revenue Q2, 2020
West Pharmaceutical Services Gross profit (Q2, 2020)195.1 M
West Pharmaceutical Services Gross profit margin (Q2, 2020), %37%
West Pharmaceutical Services Net income (Q2, 2020)91.2 M
West Pharmaceutical Services EBIT (Q2, 2020)103.6 M
West Pharmaceutical Services Cash, 30-Jun-2020445.9 M
West Pharmaceutical Services EV21.2 B

West Pharmaceutical Services Revenue

West Pharmaceutical Services revenue was $1.84 b in FY, 2019

Embed Graph

West Pharmaceutical Services Income Statement

Quarterly

USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

281.8m271.4m295.4m307.9m293.6m316.3m324.8m303.8m339.4m344.5m341.8m346.8m368.9m355.9m335.9m359.7m344.5m362.1m388.0m376.7m387.7m397.6m398.2m415.7m447.5m431.7m443.5m469.7m456.1m491.5m527.2m

Cost of goods sold

198.6m196.7m207.4m223.3m212.2m215.2m226.1m213.4m227.7m233.6m236.3m240.4m247.1m246.0m226.2m241.5m236.2m238.8m254.7m255.6m253.6m272.6m273.2m281.3m305.3m296.1m296.7m311.8m308.3m324.5m332.1m

Gross profit

83.2m74.7m88.0m84.6m81.4m101.1m98.7m90.4m111.7m110.9m105.5m106.4m121.8m109.9m109.7m118.2m108.3m123.3m133.3m121.1m134.1m125.0m125.0m134.4m142.2m135.6m146.8m157.9m147.8m167.0m195.1m

Gross profit Margin, %

30%28%30%27%28%32%30%30%33%32%31%31%33%31%33%33%31%34%34%32%35%31%31%32%32%31%33%34%32%34%37%

R&D expense

5.7m5.9m6.9m7.3m7.7m8.3m8.2m8.2m9.1m9.5m9.6m10.0m9.9m9.6m7.5m8.1m8.5m9.4m8.8m9.0m10.3m10.0m9.1m9.6m10.8m10.1m9.8m9.6m9.3m10.7m10.8m

General and administrative expense

45.8m44.9m50.6m48.5m45.7m51.3m54.4m53.7m59.1m59.7m56.1m56.4m57.5m56.0m55.2m60.8m54.6m58.1m62.5m58.3m61.6m60.6m61.5m68.3m70.0m68.6m70.3m64.8m71.8m77.7m

Operating expense total

52.7m49.4m59.2m56.8m55.3m59.4m63.1m64.1m68.4m68.4m65.8m67.1m67.7m65.9m61.9m79.1m111.8m93.3m72.1m69.8m72.8m82.3m61.1m81.0m81.9m74.8m76.1m77.4m80.5m82.5m91.5m

EBIT

30.5m25.3m28.8m27.8m26.1m41.7m35.6m26.3m43.3m42.5m39.7m39.3m54.1m44.0m47.8m39.1m(3.5m)30.0m61.2m51.3m61.3m42.7m63.9m53.4m60.3m60.8m70.7m80.5m67.3m103.6m

EBIT margin, %

11%9%10%9%9%13%11%9%13%12%12%11%15%12%14%11%(1%)8%16%14%16%11%16%13%13%14%16%17%15%20%

Interest expense

3.9m4.2m4.7m4.6m4.5m4.3m4.6m4.4m4.6m4.1m4.4m4.0m4.2m4.5m3.4m3.7m2.5m2.0m2.2m2.1m2.3m1.3m1.9m2.2m2.0m2.3m2.1m

Investment income

100.0k100.0k200.0k300.0k400.0k400.0k600.0k500.0k600.0k400.0k400.0k400.0k500.0k1.8m400.0k400.0k500.0k300.0k300.0k200.0k300.0k300.0k300.0k300.0k2.1m1.6m800.0k

Pre tax profit

26.7m21.2m24.3m23.5m22.0m37.8m20.0m22.4m39.1m38.8m35.7m35.7m50.4m41.3m44.1m36.1m(6.7m)27.8m59.5m49.3m59.5m40.7m62.9m53.7m60.1m61.1m69.9m79.6m64.9m86.5m

Income tax expense

6.6m4.5m6.1m5.3m6.6m9.8m6.5m9.0m8.6m10.3m10.6m9.8m14.0m11.7m12.5m9.2m(6.6m)6.9m17.0m14.4m2.2m2.9m14.0m12.5m6.0m8.0m16.1m15.5m10.9m

Net Income

21.7m17.8m19.6m20.1m16.9m29.2m15.6m14.8m31.7m30.2m26.8m27.1m37.6m31.0m32.9m27.8m1.5m22.1m44.7m37.6m60.9m38.8m51.0m43.6m56.1m55.2m55.4m67.3m56.3m74.3m91.2m

West Pharmaceutical Services Balance Sheet

Quarterly

USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

67.5m97.1m94.6m110.4m119.2m100.2m107.0m143.2m175.0m190.6m221.7m230.0m226.7m246.8m207.1m252.0m256.8m178.1m202.7m205.9m169.4m226.6m269.3m199.8m225.5m297.3m265.5m326.7m335.3m445.9m

Accounts Receivable

145.7m142.8m161.2m165.7m153.1m176.0m185.0m182.9m189.0m195.3m198.2m208.7m209.6m195.9m189.5m198.8m194.6m209.6m219.0m209.5m224.8m242.4m251.8m290.4m296.7m302.9m318.2m330.8m316.1m340.6m

Prepaid Expenses

40.0m44.6m56.9m61.6m65.0m34.5m32.9m36.0m35.1m33.8m30.1m44.1m44.4m36.4m33.7m33.5m48.9m39.8m41.6m46.1m37.5m40.0m37.6m36.5m43.1m57.8m54.5m61.6m

Inventories

143.3m148.4m157.1m161.2m155.5m158.2m159.2m165.9m173.5m176.5m176.7m187.5m187.9m185.7m183.4m187.2m187.7m194.1m197.7m201.1m212.3m211.3m215.8m215.7m208.2m206.8m226.1m232.3m230.4m274.8m

Current Assets

403.9m441.2m481.1m510.4m503.5m502.8m517.0m557.3m589.7m613.3m643.5m686.6m685.4m679.5m625.1m679.9m680.9m630.7m659.2m658.1m652.6m717.8m776.9m743.5m766.9m850.1m867.6m944.3m1.0b977.5m1.1b

PP&E

532.5m556.7m574.5m581.5m576.1m619.2m620.3m637.0m658.5m663.4m682.0m712.0m709.2m694.8m675.8m685.4m689.5m732.5m741.2m772.7m782.8m811.8m835.4m857.8m826.7m822.0m814.7m822.9m812.1m828.3m839.8m

Goodwill

107.9m113.8m115.2m116.1m113.6m112.7m110.0m111.5m111.0m111.7m113.4m114.2m114.0m110.4m104.4m105.3m105.7m105.7m104.9m105.2m103.5m105.8m107.1m108.8m106.6m106.3m105.2m108.2m106.6m106.9m107.6m

Total Assets

1.2b1.3b1.4b1.4b1.4b1.5b1.5b1.5b1.6b1.6b1.7b1.7b1.7b1.7b1.6b1.7b1.7b1.7b1.7b1.7b1.7b1.8b1.9b1.9b1.9b1.9b2.0b2.1b2.2b2.4b

Accounts Payable

61.4m56.3m66.2m73.4m71.7m82.7m85.6m81.3m91.6m88.4m86.3m98.4m94.5m91.4m88.5m91.4m93.6m97.5m107.3m99.0m106.1m130.9m121.9m127.6m126.2m125.2m137.7m152.1m145.3m157.9m162.3m

Short-term debt

400.0k1.4m6.3m6.3m54.7m86.5m89.1m39.3m1.7m100.0k18.9m14.2m2.2m27.2m98.8m95.0m71.0m2.5m2.5m2.6m34.4m33.8m11.7m12.1m

Current Liabilities

158.6m158.2m182.8m192.7m229.3m302.4m320.2m275.6m208.1m218.7m246.8m227.6m221.2m242.5m296.6m313.7m299.9m241.1m239.4m236.8m256.5m289.0m300.0m263.4m287.6m288.8m301.1m313.2m344.4m375.2m

Long-term debt

356.8m369.3m364.7m367.2m323.3m294.9m296.4m362.1m428.4m394.7m381.1m390.7m359.3m315.5m231.9m231.7m231.5m229.5m228.9m228.6m194.2m395.0m196.6m198.0m393.4m196.2m262.9m258.6m315.6m314.8m

Total Debt

357.2m370.7m371.0m373.5m378.0m381.4m385.5m401.4m430.1m394.8m381.1m390.7m359.3m315.5m231.9m231.7m231.5m229.5m228.9m228.6m194.2m195.7m196.6m198.0m393.4m196.2m262.9m196.0m258.6m327.3m326.9m

Total Liabilities

651.1m667.5m703.0m719.3m707.0m762.6m783.3m810.3m831.2m828.5m827.8m773.6m732.1m703.2m654.9m674.3m671.2m594.2m595.7m593.0m564.9m600.6m613.5m564.3m591.8m594.3m666.7m678.1m686.4m756.3m

Common Stock

17.5m17.7m17.8m17.8m18.0m18.0m18.0m18.3m18.4m18.4m18.6m18.7m18.7m18.8m18.8m18.8m18.8m18.8m18.8m18.8m18.8m

Preferred Stock

Additional Paid-in Capital

103.9m129.9m138.2m149.1m170.4m188.6m195.8m238.5m240.6m247.6m276.0m292.3m302.9m308.5m304.7m282.8m278.5m273.4m268.5m267.6m263.1m

Retained Earnings

788.6m825.0m855.5m878.7m927.2m947.0m939.9m978.0m1.0b1.0b1.1b1.1b1.2b1.2b1.3b1.3b1.4b1.5b1.5b1.6b

Total Equity

641.5m632.1m663.1m696.0m691.3m694.7m679.5m717.1m745.9m784.2m836.7m934.6m972.6m970.1m941.1m989.4m995.3m1.1b1.1b1.1b1.2b1.2b1.3b1.3b1.3b1.4b1.4b1.4b1.5b1.5b1.6b

Debt to Equity Ratio

0.5 x0.4 x0.4 x0.3 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.2 x0.1 x0.2 x0.1 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x0.1 x

Financial Leverage

1.9 x2.1 x2.1 x2 x2 x2.1 x2.2 x2.1 x2.1 x2.1 x2 x1.8 x1.8 x1.7 x1.7 x1.7 x1.7 x1.6 x1.5 x1.5 x1.5 x1.5 x1.5 x1.4 x1.5 x1.4 x1.5 x1.5 x1.5 x1.5 x

West Pharmaceutical Services Cash Flow

Quarterly

USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

41.6m59.3m19.6m39.7m56.7m29.2m44.8m59.6m31.7m61.9m88.7m27.1m64.7m95.7m32.9m60.7m62.2m22.1m79.2m104.5m60.9m99.7m150.7m43.6m99.7m154.9m55.4m121.5m177.8m74.3m165.5m

Depreciation and Amortization

33.2m50.4m18.3m36.5m53.9m17.5m35.2m53.6m19.4m39.1m63.1m21.8m44.9m63.9m22.0m44.2m66.6m22.3m45.0m2.0m23.3m46.8m71.8m26.4m51.9m78.1m25.5m51.8m77.1m26.0m52.4m

Cash From Operating Activities

43.1m91.1m9.5m49.2m88.9m13.8m66.0m117.6m18.9m98.4m151.7m8.8m73.0m136.9m(1.9m)75.6m144.4m3.0m79.2m147.6m20.7m106.0m181.8m45.0m127.0m215.4m47.6m152.7m260.8m57.1m205.2m

Purchases of PP&E

(32.6m)(49.8m)(19.4m)(37.8m)(62.0m)(32.4m)(69.4m)(98.4m)(61.7m)(83.8m)(113.1m)(31.7m)(56.2m)(84.8m)(30.4m)(57.1m)(86.8m)(39.0m)(74.0m)(122.7m)(37.5m)(67.0m)(101.3m)(28.0m)(48.2m)(74.7m)(28.8m)(57.1m)(88.8m)(32.1m)(69.2m)

Cash From Investing Activities

(36.6m)(55.4m)(29.1m)(52.2m)(84.2m)(31.9m)(67.8m)(93.3m)(57.7m)(81.9m)(111.0m)(35.6m)(57.0m)(77.7m)(30.6m)(56.1m)(85.6m)(38.6m)(81.2m)(129.1m)(34.7m)(70.2m)(104.2m)(28.7m)(45.7m)(72.2m)(28.7m)(75.8m)(107.4m)(31.9m)(72.8m)

Short-term Borrowings

(26.6m)(26.6m)

Long-term Borrowings

(28.9m)(29.3m)(271.2m)(93.9m)(194.0m)(244.1m)(1.6m)(44.8m)(84.1m)(68.0m)(68.6m)(69.2m)(600.0k)(1.2m)(1.8m)(28.0m)(600.0k)

Dividends Paid

(10.7m)(16.0m)(5.4m)(11.4m)(17.1m)(6.1m)(12.2m)(18.3m)(6.5m)(13.1m)(19.7m)(7.1m)(14.1m)(21.2m)(7.9m)(15.8m)(23.7m)(8.7m)(17.5m)(26.2m)(9.5m)(19.1m)(28.7m)(10.4m)(20.7m)(31.0m)(11.1m)(22.2m)(33.3m)(11.8m)(23.6m)

Cash From Financing Activities

(15.2m)(19.4m)100.0k(2.7m)3.4m24.2m18.4m26.1m55.5m15.3m18.4m26.2m(19.0m)(29.0m)1.2m(9.5m)(39.9m)(65.1m)(72.5m)(87.5m)(21.8m)(19.5m)(22.5m)(56.9m)(82.6m)(72.5m)(90.5m)(87.4m)(87.8m)(120.3m)(121.2m)

Net Change in Cash

(15.6m)14.0m(15.6m)200.0k9.0m8.4m15.2m51.4m13.1m28.7m59.8m(3.3m)16.8m(48.2m)(3.3m)1.5m(96.5m)(71.9m)(68.7m)(33.6m)23.6m66.3m(36.1m)(10.4m)61.4m(71.9m)(10.7m)58.6m(103.8m)6.8m

Income Taxes Paid

(7.9m)

West Pharmaceutical Services Ratios

USDQ2, 2010

Financial Leverage

1.9 x

West Pharmaceutical Services Employee Rating

3.3274 votes
Culture & Values
3.3
Work/Life Balance
3
Senior Management
2.9
Salary & Benefits
3.5
Career Opportunities
3.3
Source